A sporadic case of congenital aniridia caused by pericentric inversion inv(11)(p13q14) associated with a 977 kb deletion in the 11p13 region.

Aniridia, balanced chromosomal rearrangements Case report Local disbalance at the breakpoints

Journal

BMC medical genomics
ISSN: 1755-8794
Titre abrégé: BMC Med Genomics
Pays: England
ID NLM: 101319628

Informations de publication

Date de publication:
18 09 2020
Historique:
received: 30 07 2020
accepted: 02 09 2020
entrez: 19 9 2020
pubmed: 20 9 2020
medline: 9 9 2021
Statut: epublish

Résumé

Because of the significant occurrence of "WAGR-region" deletions among de novo mutations detected in congenital aniridia, DNA diagnosis is critical for all sporadic cases of aniridia due to its help in making an early diagnosis of WAGR syndrome. Standard cytogenetic karyotype study is a necessary step of molecular diagnostics in patients with deletions and in the patients' parents as it reveals complex chromosomal rearrangements and the risk of having another affected child, as well as to provide prenatal and/or preimplantation diagnostics. DNA samples were obtained from the proband (a 2-year-old boy) and his two healthy parents. Molecular analysis revealed a 977.065 kb deletion that removed loci of the ELP4, PAX6, and RCN1 genes but did not affect the coding sequence of the WT1 gene. The deletion occurred de novo on the paternal allele. The patient had normal karyotype 46,XY and a de novo pericentric inversion of chromosome 11, inv(11)(p13q14). We confirmed the diagnosis of congenital aniridia at the molecular level. For the patient, the risk of developing Wilms' tumor is similar to that in the general population. The recurrence risk for sibs in the family is low, but considering the possibility of gonadal mosaicism, it is higher than in the general population.

Sections du résumé

BACKGROUND
Because of the significant occurrence of "WAGR-region" deletions among de novo mutations detected in congenital aniridia, DNA diagnosis is critical for all sporadic cases of aniridia due to its help in making an early diagnosis of WAGR syndrome. Standard cytogenetic karyotype study is a necessary step of molecular diagnostics in patients with deletions and in the patients' parents as it reveals complex chromosomal rearrangements and the risk of having another affected child, as well as to provide prenatal and/or preimplantation diagnostics.
CASE PRESENTATION
DNA samples were obtained from the proband (a 2-year-old boy) and his two healthy parents. Molecular analysis revealed a 977.065 kb deletion that removed loci of the ELP4, PAX6, and RCN1 genes but did not affect the coding sequence of the WT1 gene. The deletion occurred de novo on the paternal allele. The patient had normal karyotype 46,XY and a de novo pericentric inversion of chromosome 11, inv(11)(p13q14).
CONCLUSIONS
We confirmed the diagnosis of congenital aniridia at the molecular level. For the patient, the risk of developing Wilms' tumor is similar to that in the general population. The recurrence risk for sibs in the family is low, but considering the possibility of gonadal mosaicism, it is higher than in the general population.

Identifiants

pubmed: 32948199
doi: 10.1186/s12920-020-00790-1
pii: 10.1186/s12920-020-00790-1
pmc: PMC7499969
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

130

Subventions

Organisme : Russian Science Foundation
ID : 17-15-01051

Références

Hum Mol Genet. 1995 Mar;4(3):415-22
pubmed: 7795596
Hum Genet. 2001 Jul;109(1):11-8
pubmed: 11479730
Am J Med Genet A. 2016 Jan;170A(1):202-9
pubmed: 26419218
Clin Genet. 2017 Dec;92(6):639-644
pubmed: 28321846
Traffic. 2018 Feb;19(2):87-104
pubmed: 29105235
Am J Med Genet A. 2008 Mar 1;146A(5):558-69
pubmed: 18241071
Am J Hum Genet. 2002 Nov;71(5):1138-49
pubmed: 12386836
N Engl J Med. 1964 Apr 30;270:922-7
pubmed: 14114111
PLoS One. 2018 Oct 5;13(10):e0205298
pubmed: 30289920
Hum Mol Genet. 2019 Oct 1;28(19):3323-3326
pubmed: 31304537
Mol Vis. 2007 Apr 02;13:511-23
pubmed: 17417613
J AAPOS. 2011 Dec;15(6):562-6
pubmed: 22153401
Nat Rev Genet. 2018 Jul;19(7):453-467
pubmed: 29692413
Am J Med Genet A. 2014 Mar;164A(3):634-8
pubmed: 24357251
Nucleic Acids Res. 2019 Jan 8;47(D1):D1038-D1043
pubmed: 30445645
Ophthalmologe. 2014 Dec;111(12):1145-56
pubmed: 25475188
BMC Genet. 2005 May 26;6:27
pubmed: 15918896

Auteurs

Tatyana A Vasilyeva (TA)

Research Centre for Medical Genetics, Moscow, Russian Federation. vasilyeva_debrie@mail.ru.

Andrey V Marakhonov (AV)

Research Centre for Medical Genetics, Moscow, Russian Federation. marakhonov@generesearch.ru.

Marina E Minzhenkova (ME)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Zhanna G Markova (ZG)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Nika V Petrova (NV)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Natella V Sukhanova (NV)

Central Clinical Hospital of the Russian Academy of Sciences, Moscow, Russian Federation.

Philipp A Koshkin (PA)

Genomed Ltd., Moscow, Russian Federation.

Denis V Pyankov (DV)

Genomed Ltd., Moscow, Russian Federation.

Ilya V Kanivets (IV)

Genomed Ltd., Moscow, Russian Federation.

Sergey A Korostelev (SA)

I.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation.

Irina A Krynskaya (IA)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Nadezhda V Shilova (NV)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Sergey I Kutsev (SI)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Vitaly V Kadyshev (VV)

Research Centre for Medical Genetics, Moscow, Russian Federation.

Rena A Zinchenko (RA)

Research Centre for Medical Genetics, Moscow, Russian Federation.
N.A. Semashko National Research Institute of Public Health, Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH